stories

Blindness drug research

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.

Researcher Professor Usha Chakravarthy of Queen’s Centre for Vision and Vascular Science explains the five things you need to know.

Read the full news story.

Arts, Humanities and Social Sciences Research Showcase

Leading researchers from the Faculty of Arts, Humanities and Social Sciences showcased their work at several venues around Belfast including the Crumlin Road Gaol and the Big Fish Sculpture on the banks of the River Lagan.

The author of the Hillsborough report, Professor Phil Scraton, reflected on the significant impact of his work as a key member of the Hillsborough Independent Panel in his talk Recovering Truth, Informing Justice: Researching the Hillsborough Disaster.

The day’s programme is organised by the Research and Enterprise Directorate and the , as part of the University’s ‘Local Talent, Global Impact’ initiative.

New lab to revolutionise cancer research and diagnosis

A new cancer facility at Queen’s, the first integrated laboratory of its kind in the UK and Ireland, is to revolutionise cancer research and diagnosis for thousands of patients across Northern Ireland.

The new facility is a partnership between Queen’s Centre for Cancer Research and Cell Biology and the Belfast Health and Social Care Trust.

Read the full news release.

New plasma jet gives ‘cold’ shoulder to superbugs

Scientists in the School of Mathematics and Physics and the School of Pharmacy at Queen’s have developed a new technique which has the potential to kill off hospital superbugs like C. difficile and MRSA.

Read the full release online.

Local Talent, Global Impact research showcase

People behind some of the biggest research breakthroughs in recent times have been showcasing their work at the event ‘Local Talent Global Impact’.

Trading room opens

Northern Ireland’s first ever financial trading room has opened at Queen’s.

Replicating the stock exchanges of New York and London, The First Derivatives Trading Room (FDTR), will provide a dynamic learning environment for students hoping to embark in a career in financial services or technology.

Read the full news release.

QUBIS: Alan Clarke

Alan Clarke, Technical Director, PDC Ltd discusses their company's work with QUBIS.

QUBIS: Donald Denvir

Dr Donald Denvir, Technical Director, ANDOR Technologies PLC talks about ANDOR and their relationship with QUBIS.

QUBIS: Mark Kelly

Dr mark Kelly, CEO, Lamhroe Ldt, discusses how Queen's helped the company.

QUBIS: Sheena Lewis

Professor Sheena Lewis, CEO, Lewis Fertility Ltd talks about her company's work with QUBIS.

QUBIS: Hugh Cormican

Dr Hugh Cormican, CEO, Cirdan Ltd, talks about setting up a world-class company at Queen's.

QUBIS: Professor Sir Peter Gregson

Queen's Vice-Chancellor, Professor Sir Peter Gregson, talks about the background and work of QUBIS.

QUBIS: Gordon Bell

Gordon Bell, Chairman, QUBIS Ltd.